Advertisement

Cost of Tobacco-related Cancer Hospitalizations in the U.S., 2014

Published:February 04, 2018DOI:https://doi.org/10.1016/j.amepre.2017.12.004

      Introduction

      Smoking has been causally linked to 12 tobacco-related cancers: oral cavity and pharynx, esophagus, stomach, colon and rectum, liver, pancreas, larynx, lung, cervix, bladder, kidney, and acute myeloid leukemia. Tobacco-related cancers−related morbidity and mortality have been well described, but little is known about the prevalence of tobacco-related cancer hospitalizations and associated costs. This study estimates the annual number of tobacco-related cancer hospitalizations and their associated direct medical costs in the U.S.

      Methods

      This study examined data from the 2014 National Inpatient Sample, the largest publicly available all-payer inpatient care database in the U.S. The authors calculated number of hospitalizations, total costs, length of stay, and cost per stay for tobacco-related cancer hospitalizations and cancer hospitalizations not related to tobacco.

      Results

      In 2014, there were an estimated 461,295 annual tobacco-related cancer hospitalizations at a cost of $8.2 billion in the U.S. Tobacco-related cancers accounted for 45% of total cancer hospitalizations and cancer hospitalization costs. Compared with cancer hospitalizations not related to tobacco, tobacco-related cancer hospitalizations had a longer mean length of stay (6.8 vs 5.7 days).

      Conclusions

      The burden of tobacco-related cancer hospitalizations is substantial in the U.S. These findings highlight the importance of tobacco prevention and cessation efforts to decrease the burden of tobacco-related cancers in the U.S.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • U.S. DHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
        The Health Consequences of Smoking50 Years of Progress: A Report of the Surgeon General.
        CDC, Atlanta, GA2014
        • Balogh E.P.
        • Dresler C.
        • Fleury M.E.
        • et al.
        Reducing tobacco-related cancer incidence and mortality: summary of an Institute of Medicine workshop.
        Oncologist. 2014; 19: 21-31https://doi.org/10.1634/theoncologist.2013-0230
        • CDC
        Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 1226-1228
        • Stewart S.L.
        • Cardinez C.J.
        • Richardson L.C.
        • et al.
        Surveillance for cancers associated with tobacco use—United States, 1999–2004.
        MMWR Surveill Summ. 2008; 57: 1-33
        • Henley S.J.
        • Thomas C.C.
        • Sharapova S.R.
        • et al.
        Vital signs: disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1212-1218https://doi.org/10.15585/mmwr.mm6544a3
        • Fox K.M.
        • Brooks J.M.
        • Kim J.
        Metastatic non-small cell lung cancer: costs associated with disease progression.
        Am J Manag Care. 2008; 14: 565-571
        • Kutikova L.
        • Bowman L.
        • Chang S.
        • Long S.R.
        • Obasaju C.
        • Crown W.H.
        The economic burden of lung cancer and the associated costs of treatment failure in the United States.
        Lung Cancer. 2005; 50: 143-154https://doi.org/10.1016/j.lungcan.2005.06.005
        • Hillner B.E.
        • McDonald M.K.
        • Desch C.E.
        • et al.
        Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.
        J Clin Oncol. 1998; 16: 1420-1424https://doi.org/10.1200/JCO.1998.16.4.1420
        • Fireman B.H.
        • Quesenberry C.P.
        • Somkin C.P.
        • et al.
        Cost of care for cancer in a health maintenance organization.
        Health Care Financ Rev. 1997; 18: 51-76
      1. Agency for Healthcare Research and Quality. HCUP databases. Healthcare Cost and Utilization Project (HCUP). www.hcup-us.ahrq.gov/kidoverview.jsp. Published February 2016. Accessed January 2018.

        • Siegel R.L.
        • Jacobs E.J.
        • Newton C.C.
        • et al.
        Deaths due to cigarette smoking for 12 smoking-related cancers in the United States.
        JAMA Intern Med. 2015; 175: 1574-1576https://doi.org/10.1001/jamainternmed.2015.2398
      2. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). www.cdc.gov/nchs/icd/icd9cm.htm. Published 2016. Accessed January 2018.

        • Graubard B.I.
        • Korn E.L.
        Predictive margins with survey data.
        Biometrics. 1999; 55: 652-659https://doi.org/10.1111/j.0006-341X.1999.00652.x
      3. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP). Cost-to-charge ratio files. https://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. Published 2015. Accessed December 31, 2017.

        • Xu X.
        • Bishop E.E.
        • Kennedy S.M.
        • Simpson S.A.
        • Pechacek T.F.
        Annual healthcare spending attributable to cigarette smoking: an update.
        Am J Prev Med. 2015; 48: 326-333https://doi.org/10.1016/j.amepre.2014.10.012
        • Warner K.E.
        • Hodgson T.A.
        • Carroll C.E.
        Medical costs of smoking in the United States: estimates, their validity, and their implications.
        Tob Control. 1999; 8: 290-300https://doi.org/10.1136/tc.8.3.290
        • Maciosek M.V.
        • Xu X.
        • Butani A.L.
        • Pechacek T.F.
        Smoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approach.
        Prev Med. 2015; 77: 162-167https://doi.org/10.1016/j.ypmed.2015.05.019
        • Solberg L.I.
        • Maciosek M.V.
        • Edwards N.M.
        • Khanchandani H.S.
        • Goodman M.J.
        Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.
        Am J Prev Med. 2006; 31: 62-71https://doi.org/10.1016/j.amepre.2006.03.013
        • Miller V.P.
        • Ernst C.
        • Collin F.
        Smoking-attributable medical care costs in the USA.
        Soc Sci Med. 1999; 48: 375-391https://doi.org/10.1016/S0277-9536(98)00344-X
        • Jamal A.
        • King B.A.
        • Neff L.J.
        • Whitmill J.
        • Babb S.D.
        • Graffunder C.M.
        Current cigarette smoking among adults—United States, 2005–2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1205-1211https://doi.org/10.15585/mmwr.mm6544a2
        • Thun M.J.
        • Carter B.D.
        • Feskanich D.
        • et al.
        50-year trends in smoking-related mortality in the United States.
        N Engl J Med. 2013; 368: 351-364https://doi.org/10.1056/NEJMsa1211127
        • Jha P.
        • Ramasundarahettige C.
        • Landsman V.
        • et al.
        21st-century hazards of smoking and benefits of cessation in the United States.
        N Engl J Med. 2013; 368: 341-350https://doi.org/10.1056/NEJMsa1211128
        • CDC
        Best Practices for Comprehensive Tobacco Control Programs.
        U.S. DHHS, CDC, National Center for Chronic Disease and Health Promotion, Office on Smoking and Health, Atlanta, GA2014
        • National Academy of Medicine
        Ending the Tobacco Problem; A Blueprint for the Nation.
        The National Academies Press, Washington, DC2007
        • Jemal A.
        • Thun M.J.
        • Ries L.A.
        • et al.
        Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control.
        J Natl Cancer Inst. 2008; 100: 1672-1694https://doi.org/10.1093/jnci/djn389
        • McAfee T.
        • Davis K.C.
        • Shafer P.
        • Patel D.
        • Alexander R.
        • Bunnell R.
        Increasing the dose of television advertising in a national antismoking media campaign: results from a randomised field trial.
        Tob Control. 2017; 26: 19-28https://doi.org/10.1136/tobaccocontrol-2015-052517
        • Rigotti N.A.
        • Regan S.
        • Levy D.E.
        • et al.
        Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial.
        JAMA. 2014; 312: 719-728https://doi.org/10.1001/jama.2014.9237
        • Levy D.E.
        • Klinger E.V.
        • Linder J.A.
        • et al.
        Cost-effectiveness of a health system-based smoking cessation program.
        Nicotine Tob Res. 2017; 19: 1508-1515https://doi.org/10.1093/ntr/ntw243
        • Toll B.A.
        • Brandon T.H.
        • Gritz E.R.
        • Warren G.W.
        • Herbst R.S.
        Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement.
        Clin Cancer Res. 2013; 19: 1941-1948https://doi.org/10.1158/1078-0432.CCR-13-0666
        • Underwood J.M.
        • Townsend J.S.
        • Tai E.
        • White A.
        • Davis S.P.
        • Fairley T.L.
        Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis.
        J Cancer Surviv. 2012; 6: 333-344https://doi.org/10.1007/s11764-012-0230-1
        • Yabroff K.R.
        • Lamont E.B.
        • Mariotto A.
        • et al.
        Cost of care for elderly cancer patients in the United States.
        J Natl Cancer Inst. 2008; 100: 630-641https://doi.org/10.1093/jnci/djn103